Paper34725151
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy.
Ho WW and 23 others. Proc Natl Acad Sci U S A, 2021. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy. Papers, record 34725151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34725151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Immune Checkpoint Inhibitors | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Line, Tumor | |
| DNA Mismatch Repair | |
| Dendritic Cells | |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Interferon-gamma | |
| Male | |
| Mice, Inbred C57BL | |
| Mice |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA259253 | NCI NIH HHS | United States | R01CA259253 | PubMed and NIH | NIH RePORTER |
| R01 CA260872 | NCI NIH HHS | United States | R01CA260872 | PubMed and NIH | NIH RePORTER |
| P30 CA014051 | NCI NIH HHS | United States | P30CA014051 | PubMed and NIH | NIH RePORTER |
| P01 CA080124 | NCI NIH HHS | United States | P01CA080124 | PubMed and NIH | NIH RePORTER |
| R01 CA208205 | NCI NIH HHS | United States | R01CA208205 | PubMed and NIH | NIH RePORTER |
| R01 CA206890 | NCI NIH HHS | United States | R01CA206890 | PubMed and NIH | NIH RePORTER |
| R01 NS118929 | NINDS NIH HHS | United States | R01NS118929 | PubMed and NIH | NIH RePORTER |
| R01 CA260857 | NCI NIH HHS | United States | R01CA260857 | PubMed and NIH | NIH RePORTER |
| U01 CA224348 | NCI NIH HHS | United States | U01CA224348 | PubMed and NIH | NIH RePORTER |
| R01 AI084880 | NIAID NIH HHS | United States | R01AI084880 | PubMed and NIH | NIH RePORTER |
| R01 CA218579 | NCI NIH HHS | United States | R01CA218579 | PubMed and NIH | NIH RePORTER |
| R35 CA197743 | NCI NIH HHS | United States | R35CA197743 | PubMed and NIH | NIH RePORTER |
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29942093 | A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. | Nat Med | 2018 | https://conductscience.org/library/papers/29942093 | PubMed |
| 2 | 19460966 | Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. | Science | 2009 | https://conductscience.org/library/papers/19460966 | PubMed |
| 3 | 8920882 | Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. | J Exp Med | 1996 | https://conductscience.org/library/papers/8920882 | PubMed |
| 4 | 21930765 | Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. | J Exp Med | 2011 | https://conductscience.org/library/papers/21930765 | PubMed |
| 5 | 32042168 | Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy. | Nat Biotechnol | 2020 | https://conductscience.org/library/papers/32042168 | PubMed |
| 6 | 31645760 | MHC-II neoantigens shape tumour immunity and response to immunotherapy. | Nature | 2019 | https://conductscience.org/library/papers/31645760 | PubMed |
| 7 | 23323831 | GSVA: gene set variation analysis for microarray and RNA-seq data. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23323831 | PubMed |
| 8 | 25274032 | Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. | Cancer Res | 2014 | https://conductscience.org/library/papers/25274032 | PubMed |
| 9 | 27096321 | Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. | Immunity | 2016 | https://conductscience.org/library/papers/27096321 | PubMed |
| 10 | 29567705 | Cancer immunotherapy using checkpoint blockade. | Science | 2018 | https://conductscience.org/library/papers/29567705 | PubMed |
| 11 | 19451168 | Fast and accurate short read alignment with Burrows-Wheeler transform. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19451168 | PubMed |
| 12 | 10352881 | Orthotopic models are necessary to predict therapy of transplantable tumors in mice. | Cancer Metastasis Rev | 1998 | https://conductscience.org/library/papers/10352881 | PubMed |
| 13 | 27050669 | Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy. | PLoS One | 2016 | https://conductscience.org/library/papers/27050669 | PubMed |
| 14 | 27339708 | The role of myeloid cells in cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27339708 | PubMed |
| 15 | 23950696 | Software for computing and annotating genomic ranges. | PLoS Comput Biol | 2013 | https://conductscience.org/library/papers/23950696 | PubMed |
| 16 | 28691930 | Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28691930 | PubMed |
| 17 | 33591350 | Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/33591350 | PubMed |
| 18 | 28900008 | Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28900008 | PubMed |
| 19 | 16320114 | Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth. | Clin Exp Metastasis | 2005 | https://conductscience.org/library/papers/16320114 | PubMed |
| 20 | 24621249 | Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. | BMC Genomics | 2014 | https://conductscience.org/library/papers/24621249 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928874 | Nanotechnology-Enabled Immunotherapy for Colorectal Cancer: Overcoming the "Cold" Tumor Microenvironment in Microsatellite-Stable Disease. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42928874 | PubMed |
| 42909684 | Biomarkers and future directions for immunotherapy in microsatellite-stable colorectal cancer: a systematic review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42909684 | PubMed |
| 42857020 | Multipathway pharmacological interventions targeting liver-derived immune resistance in colorectal cancer liver metastasis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42857020 | PubMed |
| 42802117 | [A transition from targeting immune evasion to a multidisciplinary collaborative treatment framework for "homotherapy for heteropathy" in liver metastases]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42802117 | PubMed |
| 42769402 | Beyond mismatch repair in colorectal cancer liver metastases: rethinking immunotherapy through the hepatic metastatic niche. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769402 | PubMed |
| 42756094 | Traditional Chinese medicine remodels the immune microenvironment of colorectal cancer: mechanisms and therapeutic perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42756094 | PubMed |
| 42683268 | Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling. | Front Immunol | 2026 | https://conductscience.org/library/papers/42683268 | PubMed |
| 42640115 | Iron-Tannic Acid Hydrogel Mediated Mild Photothermal Therapy Combined With Ferroptosis Enhances Anti-Tumor Immunity in Colorectal Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42640115 | PubMed |
| 42557403 | Fc-optimized GITR antibody enhances a CD4 T cell-dendritic cell crosstalk to promote antitumor immunity. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42557403 | PubMed |
| 42511550 | Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511550 | PubMed |
| 42274217 | The Role of High-Intensity Focused Ultrasound as a Local Consolidative Therapy in Multimodal Conversion Treatment for Colorectal Liver Metastases: A Case Series. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42274217 | PubMed |
| 42253947 | Organ-specific pre-metastatic and metastatic niches in colorectal cancer: "discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis". | Front Immunol | 2026 | https://conductscience.org/library/papers/42253947 | PubMed |
| 42228092 | Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity. | Cancer Res | 2026 | https://conductscience.org/library/papers/42228092 | PubMed |
| 42206444 | Mitochondria-Targeting Iridium(III) Complexes Induce PANoptosis and Ferroptosis for Boosting Chemoimmunotherapy Against Immune-Desert Colorectal Cancer. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42206444 | PubMed |
| 42166776 | Enhancing Immunotherapeutic Response in Colorectal Cancer with a Neuropilin 1-Targeting Tumor-Penetrating Peptide. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/42166776 | PubMed |
| 42024470 | DYRK1A enhances antitumor immunity in type 1 conventional dendritic cells via mTORC1 activation. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42024470 | PubMed |
| 41977468 | The Molecular Signature of Early-Onset Colorectal Cancer Liver Metastases: Distinct Biology and Clinical Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977468 | PubMed |
| 41904143 | NEK8 kinase-mediated lactate increase impairs antitumor immunity decreasing radiotherapy sensitivity in colorectal cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/41904143 | PubMed |
| 41783896 | Research progress on immune tolerance mechanisms in liver metastatic tumors and the "Liver-metastasis-oriented shared-mechanism therapeutic strategy" approach. | Med Rev (2021) | 2026 | https://conductscience.org/library/papers/41783896 | PubMed |
| 41410751 | Spatial patterns and prognostic relevance of CD1a+ immature and CD208+ mature dendritic cells in colorectal cancer from non-tumor adjacent mucosa to liver metastases. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/41410751 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34725151
GET https://conductscience.org/api/papers/v1/34725151/authors?page=2